News & Press Releases

Integrity Applications Receives CE Mark Approval for Self-Calibration Version of its GlucoTrack® Non-Invasive Glucose Monitoring Device

January 21st, 2020

Major Milestone Simplifies Use and Opens Up Additional Sales and Distribution Channels Wilmington, DE and Ashdod, Israel, Jan. 21, 2020 (GLOBE NEWSWIRE) — Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes and prediabetes, announced today that it has received CE Mark approval […]

Read More

Integrity Applications Announces the Appointment of David Malka as President

November 19th, 2019

Integrity Applications Announces the Appointment of David Malka as President Company Co-Founder Takes on New Leadership Position   Wilmington, DE and Ashdod, Israel, November 19, 2019 (GLOBE NEWSWIRE) — Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today the […]

Read More

Integrity Applications Announces the Appointment of Allen E. Danzig to its Board of Directors and as Chair of the Nominating, Governance and Compensation Committee

November 4th, 2019

New Independent Director Brings Significant Public Company Leadership And Corporate Governance Experience Wilmington, DE and Ashdod, Israel, Nov. 04, 2019 (GLOBE NEWSWIRE) — Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today the appointment of Allen E. Danzig to […]

Read More

Integrity Applications Announces the Appointment of Robert T. Guest as Senior Advisor

May 16th, 2019

  Integrity Applications Announces the Appointment of Robert T. Guest as Senior Advisor   Industry Executive to Advise on Global Commercial Strategy   Wilmington, DE and Ashdod, Israel – May 16th, 2019 – Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes […]

Read More Download

Integrity Applications Announces GlucoTrack® Customer Experience Program in the Netherlands

December 17th, 2018

Integrity Applications Announces GlucoTrack® Customer Experience Program in the Netherlands Wilmington, DE and Ashdod, Israel – December 17th, 2018 – Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that the Company has launched a Customer Experience Program […]

Read More Download

Integrity Applications Announces GlucoTrack® Product Milestones

December 7th, 2018

Integrity Applications Announces GlucoTrack® Product Milestones * GlucoTrack® Link wireless module receives CE approval, further enhancing the GlucoTrack® solution. * GlucoTrack® receives certification to the IEC 60601-1-2 standard in compliance with the January 2019 mandate. * GlucoTrack® CE Marking gains renewal based on the ISO 13485 and MDD Annex II standards for product and  service […]

Read More Download

Integrity Applications Announces Executive Leadership Changes

October 9th, 2018

Integrity Applications Announces Executive Leadership Changes   Wilmington, DE and Ashdod, Israel – October 9, 2018 – Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, today announced that John Graham has resigned as chief executive officer and chairman for […]

Read More Download

Integrity Applications Receives First Order from CuraTec Nordic for GlucoTrack®

August 14th, 2018

Wilmington, DE and Ashdod, Israel – August 14th, 2018 – Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has received its first order from CuraTec Nordic http://www.curatec.dk its exclusive distributor for the Nordic Countries. Kim Frederiksen, […]

Read More Download

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries

July 25th, 2018

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Glucose Monitoring Device in the Nordic Countries Wilmington, DE and Ashdod, Israel – July 25th, 2018 – Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP) (“Integrity” or “Integrity Applications”) announced today that it has entered into an exclusive distribution agreement with CuraTec Nordic, a Scandinavian medical device distributor. The […]

Read More Download

Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Non-Invasive Glucose Monitoring Device in the Netherlands

December 28th, 2017

  Integrity Applications Signs Distribution Agreement for Its GlucoTrack® Non-Invasive Glucose Monitoring Device in the Netherlands Contract Represents Important First Step in European Re-Launch   Wilmington, DE and Ashdod, Israel – December 28, 2017 – Integrity Applications, Inc. (“Integrity”) (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type […]

Read More Download

Integrity Applications Announces Re-Order of GlucoTrack® Devices

November 1st, 2017

  Integrity Applications Announces Re-Order of GlucoTrack® Devices Wilmington, DE and Ashdod, Israel – November 1 2017 – Integrity Applications, Inc. (OTCQB: IGAP) (“Integrity” or the “Company”), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced that it has received the largest single re-order of […]

Read More Download

Integrity Applications Announces Strategic Corporate Update

October 23rd, 2017

Exhibit 99.2   Integrity Applications Announces Strategic Corporate Update Near-term Priorities Include GlucoTrack Commercialization in Europe and GlucoTrack US FDA Approval Wilmington, DE and Ashdod, Israel,  – October 23 2017, Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with Type 2 diabetes,  announced a strategic corporate […]

Read More Download

A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes

September 7th, 2017

A truly non-invasive glucose monitoring device that may improve diabetes management in patients with type 2 diabetes or prediabetes   Wilmington, Delaware, and Ashdod, Israel, September 7, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, presents Data Demonstrating that the […]

Read More Download

GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal

September 6th, 2017

GlucoTrack® presents an innovation in type 2 diabetes management at the upcoming EASD in Lisbon, Portugal Wilmington, Delaware, and Ashdod, Israel, September 8, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), innovator of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes, announced today that it will be attending the 53rd […]

Read More Download

Integrity Applications Announces Close of $12 Million Private Placement

August 2nd, 2017

Integrity Applications Announces Close of $12 Million Private Placement Wilmington, Delaware, and Ashdod, Israel, August 2nd, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes, announced today that it has successfully closed a private placement offering, raising approximately $12 […]

Read More Download

Integrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association’s 77th Scientific Sessions

June 12th, 2017

Integrity Applications Presents Data Demonstrating that the Accuracy of GlucoTrack® Is Independent of Medication Regime at American Diabetes Association’s 77th Scientific Sessions   GlucoTrack Accuracy Maintained in People with Type 2 Diabetes Using a Variety of Medications for Comorbid Conditions   97.5% to 99.2% of GlucoTrack Glucose Measurements Maintain Clinically Acceptable A and B Zones […]

Read More Download

Integrity Applications, GlucoTrack® Innovator, Names David Podwalski as Chief Commercial Officer

June 8th, 2017

 Integrity Applications, GlucoTrack® Innovator, Names David Podwalski as Chief Commercial Officer   Wilmington, Delaware, and Ashdod, Israel, June 8, 2017 — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels in people with type 2 diabetes and prediabetes, today announced the appointment of David Podwalski as Chief Commercial Officer.   […]

Read More Download

Integrity Applications, GlucoTrack ® Innovator, Expands Board of Directors with the Appointment of Michael Hauck

May 25th, 2017

Wilmington, Delaware, and Ashdod, Israel, May 25, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced the appointment of Michael Hauck to its Board of Directors. John Graham, CEO and Chairman of Integrity Applications, remarked, “We are […]

Read More Download

Integrity Applications to Present GlucoTrack® Data at American Diabetes Association’s 77th Scientific Sessions

May 23rd, 2017

Integrity Applications to Present GlucoTrack® Data at American Diabetes Association’s 77th Scientific Sessions Wilmington, Delaware, and Ashdod, Israel, May 23, 2017 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with type 2 diabetes and prediabetes, today announced that the results of a study evaluating the […]

Read More Download

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter